Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Explore Visa cards that offer the best cashback without any annual fees. Start saving on your purchases effortlessly.
28,655 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Vitalik Buterin unveiled a three-part framework for Ethereum, aiming to reshape the network’s use case and potentiall...
Rocket Lab climbs on Neutron milestones as investors weigh SpaceX IPO chatter. The move underscores growing appetite ...
A majority of Americans fear AI-driven job losses will push the cost and effort of buying a home out of reach, accord...
Ark Invest disclosed a new Alphabet stake, triggering debate over Google’s growth drivers and the broader tech rally....
A landmark analysis of Swedish twins suggests genetics may influence about 45% of how people invest, from trading fre...
Title insurance premium volume surged nearly 14% in 2025, driven by stronger mortgage activity and ongoing demand for...
As mega-cap tech valuations wobble, a rare under-$30 stock with solid cash flow and a growing media footprint stands ...
Dubai's property market is cooling as buyers pull back and prices fall. Analysts weigh whether the dip is a temporary...
Newfi Lending is rolling out Prudent AI's IncomeIQ in its broker portal, delivering near real-time non-QM income anal...
Micron shares slide 6% and Western Digital declines 5% in midday trading, even as SanDisk steadies. The move comes as...
Two key negotiations on the CLARITY Act fell apart, effectively killing the July 4 deadline and leaving crypto regula...